EIF2AK3 and Parkinson disease: β-Asarone exhibits similar effects by reducing GRP78, p-PERK, and CHOP expression at both mRNA and protein levels in the striatum of Parkinson’s disease rats, thereby mitigating ER stress and autophagy via the PERK/eIF2α pathway (Ning et al., 2019).